cloudfront

Report Detail



OtherGlobal Asthma and COPD Drug Market Insights, Forecast to 2025

  • RnM2315946
  • |
  • 8 August, 2018
  • |
  • Global
  • |
  • 98 pages
  • |
  • QYResearch
  • |
  • Other

Global Asthma and COPD Drug Market Insights, Forecast to 2025

Table of Contents

    1 Study Coverage

    • 1.1 Asthma and COPD Drug Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Asthma and COPD Drug Market Size Growth Rate by Product
      • 1.4.2 Bronchodilators
      • 1.4.3 Anti-inflammatory Drugs
      • 1.4.4 Monoclonal Antibodies
      • 1.4.5 Combination Drugs
    • 1.5 Market by End User
      • 1.5.1 Global Asthma and COPD Drug Market Size Growth Rate by End User
      • 1.5.2 Asthma
      • 1.5.3 COPD
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Asthma and COPD Drug Market Size
      • 2.1.1 Global Asthma and COPD Drug Revenue 2013-2025
      • 2.1.2 Global Asthma and COPD Drug Sales 2013-2025
    • 2.2 Asthma and COPD Drug Growth Rate by Regions
      • 2.2.1 Global Asthma and COPD Drug Sales by Regions
      • 2.2.2 Global Asthma and COPD Drug Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Asthma and COPD Drug Sales by Manufacturers
      • 3.1.1 Asthma and COPD Drug Sales by Manufacturers
      • 3.1.2 Asthma and COPD Drug Sales Market Share by Manufacturers
      • 3.1.3 Global Asthma and COPD Drug Market Concentration Ratio (CR5 and HHI)
    • 3.2 Asthma and COPD Drug Revenue by Manufacturers
      • 3.2.1 Asthma and COPD Drug Revenue by Manufacturers (2013-2018)
      • 3.2.2 Asthma and COPD Drug Revenue Share by Manufacturers (2013-2018)
    • 3.3 Asthma and COPD Drug Price by Manufacturers
    • 3.4 Asthma and COPD Drug Manufacturing Base Distribution, Product Types
      • 3.4.1 Asthma and COPD Drug Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Asthma and COPD Drug Product Type
      • 3.4.3 Date of International Manufacturers Enter into Asthma and COPD Drug Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Asthma and COPD Drug Sales by Product
    • 4.2 Global Asthma and COPD Drug Revenue by Product
    • 4.3 Asthma and COPD Drug Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Asthma and COPD Drug Breakdown Data by End User

    6 North America

    • 6.1 North America Asthma and COPD Drug by Countries
      • 6.1.1 North America Asthma and COPD Drug Sales by Countries
      • 6.1.2 North America Asthma and COPD Drug Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Asthma and COPD Drug by Product
    • 6.3 North America Asthma and COPD Drug by End User

    7 Europe

    • 7.1 Europe Asthma and COPD Drug by Countries
      • 7.1.1 Europe Asthma and COPD Drug Sales by Countries
      • 7.1.2 Europe Asthma and COPD Drug Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Asthma and COPD Drug by Product
    • 7.3 Europe Asthma and COPD Drug by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Asthma and COPD Drug by Countries
      • 8.1.1 Asia Pacific Asthma and COPD Drug Sales by Countries
      • 8.1.2 Asia Pacific Asthma and COPD Drug Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Asthma and COPD Drug by Product
    • 8.3 Asia Pacific Asthma and COPD Drug by End User

    9 Central & South America

    • 9.1 Central & South America Asthma and COPD Drug by Countries
      • 9.1.1 Central & South America Asthma and COPD Drug Sales by Countries
      • 9.1.2 Central & South America Asthma and COPD Drug Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Asthma and COPD Drug by Product
    • 9.3 Central & South America Asthma and COPD Drug by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Asthma and COPD Drug by Countries
      • 10.1.1 Middle East and Africa Asthma and COPD Drug Sales by Countries
      • 10.1.2 Middle East and Africa Asthma and COPD Drug Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Asthma and COPD Drug by Product
    • 10.3 Middle East and Africa Asthma and COPD Drug by End User

    11 Company Profiles

    • 11.1 Boehringer Ingelheim
      • 11.1.1 Boehringer Ingelheim Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Boehringer Ingelheim Asthma and COPD Drug Sales, Revenue and Gross Margin (2013-2018)
      • 11.1.4 Boehringer Ingelheim Asthma and COPD Drug Products Offered
      • 11.1.5 Boehringer Ingelheim Recent Development
    • 11.2 GlaxoSmithKline
      • 11.2.1 GlaxoSmithKline Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 GlaxoSmithKline Asthma and COPD Drug Sales, Revenue and Gross Margin (2013-2018)
      • 11.2.4 GlaxoSmithKline Asthma and COPD Drug Products Offered
      • 11.2.5 GlaxoSmithKline Recent Development
    • 11.3 Merck and Co
      • 11.3.1 Merck and Co Company Details
      • 11.3.2 Company Business Overview
    • 11.3.Merck and Co Asthma and COPD Drug Sales, Revenue and Gross Margin (2013-2018)
      • 11.3.4 Merck and Co Asthma and COPD Drug Products Offered
      • 11.3.5 Merck and Co Recent Development
    • 11.4 Novartis AG
      • 11.4.1 Novartis AG Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Novartis AG Asthma and COPD Drug Sales, Revenue and Gross Margin (2013-2018)
      • 11.4.4 Novartis AG Asthma and COPD Drug Products Offered
      • 11.4.5 Novartis AG Recent Development
    • 11.5 AstraZeneca
      • 11.5.1 AstraZeneca Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 AstraZeneca Asthma and COPD Drug Sales, Revenue and Gross Margin (2013-2018)
      • 11.5.4 AstraZeneca Asthma and COPD Drug Products Offered
      • 11.5.5 AstraZeneca Recent Development
    • 11.6 F. Hoffmann-La Roche
      • 11.6.1 F. Hoffmann-La Roche Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 F. Hoffmann-La Roche Asthma and COPD Drug Sales, Revenue and Gross Margin (2013-2018)
      • 11.6.4 F. Hoffmann-La Roche Asthma and COPD Drug Products Offered
      • 11.6.5 F. Hoffmann-La Roche Recent Development

    12 Future Forecast

    • 12.1 Asthma and COPD Drug Market Forecast by Regions
      • 12.1.1 Global Asthma and COPD Drug Sales Forecast by Regions 2018-2025
      • 12.1.2 Global Asthma and COPD Drug Revenue Forecast by Regions 2018-2025
    • 12.2 Asthma and COPD Drug Market Forecast by Product
      • 12.2.1 Global Asthma and COPD Drug Sales Forecast by Product 2018-2025
      • 12.2.2 Global Asthma and COPD Drug Revenue Forecast by Product 2018-2025
    • 12.3 Asthma and COPD Drug Market Forecast by End User
    • 12.4 North America Asthma and COPD Drug Forecast
    • 12.5 Europe Asthma and COPD Drug Forecast
    • 12.6 Asia Pacific Asthma and COPD Drug Forecast
    • 12.7 Central & South America Asthma and COPD Drug Forecast
    • 12.8 Middle East and Africa Asthma and COPD Drug Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Asthma and COPD Drug Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      This report studies the global market size of Asthma and COPD Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Asthma and COPD Drug in these regions.
      This research report categorizes the global Asthma and COPD Drug market by top players/brands, region, type and end user. This report also studies the global Asthma and COPD Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      Asthma and chronic obstructive pulmonary disease (Asthma/COPD) are a common type of chronic disease. Once they are sick, they usually need long-term medication, which seriously affects people's quality of life.
      The 2016 Global Asthma Prevention Initiative (GINA) organization has re-released its Consensus on Asthma, COPD and Asthma-COPD Overlap Syndrome, developed in collaboration with the Global Scientific Committee on Chronic Obstructive Pulmonary Disease Prevention (GOLD). A method of identifying such patients is provided.
      The global Asthma and COPD Drug market is valued at 5200 million US$ in 2017 and will reach 8040 million US$ by the end of 2025, growing at a CAGR of 5.6% during 2018-2025. The objectives of this study are to define, segment, and project the size of the Asthma and COPD Drug market based on company, product type, end user and key regions.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Boehringer Ingelheim
      GlaxoSmithKline
      Merck and Co
      Novartis AG
      AstraZeneca
      F. Hoffmann-La Roche

      Market size by Product
      Bronchodilators
      Anti-inflammatory Drugs
      Monoclonal Antibodies
      Combination Drugs
      Market size by End User
      Asthma
      COPD

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Asthma and COPD Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2017, and forecast to 2025.
      To understand the structure of Asthma and COPD Drug market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Asthma and COPD Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Asthma and COPD Drug submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Asthma and COPD Drug are as follows:
      History Year: 2013-2017
      Base Year: 2017
      Estimated Year: 2018
      Forecast Year 2018 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Asthma and COPD Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.




      Summary:
      Get latest Market Research Reports on Asthma and COPD Drug. Industry analysis & Market Report on Asthma and COPD Drug is a syndicated market report, published as Global Asthma and COPD Drug Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Asthma and COPD Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $4,900.00
      $9,800.00
      3,290.35
      6,580.70
      4,508.98
      9,017.96
      593,586.00
      1,187,172.00
      324,935.66
      649,871.32
      Add To Cart Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report